J
James Rucker
Senior Clinical Lecturer at King's College London
Key Impact
Leads the Psychedelic Trials Group investigating psilocybin for treatment-resistant depression.
Background & Research
James Rucker is a consultant psychiatrist and leading trialist in the UK. He heads the Psychedelic Trials Group at the Institute of Psychiatry, Psychology & Neuroscience, where he conducts clinical trials on psilocybin, MDMA, and ketamine. His work focuses on integrating these pharmacological breakthroughs with psychotherapeutic frameworks for psychiatric recovery.
Focus Areas
PsilocybinClinical TrialsDepressionMood Disorders